Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2015; 5(6):597-608. doi:10.7150/thno.11546 This issue Cite

Research Paper

Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer

Xianlei Sun1*, Duo Gao1*, Liquan Gao1, Chenran Zhang1, Xinhe Yu1, Bing Jia1, Fan Wang1,2, Zhaofei Liu1✉

1. Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China;
2. Interdisciplinary Laboratory, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
*These authors contributed equally to this work.

✉ Corresponding author: Zhaofei Liu, Ph.D., Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China. Phone: +86-10-82802871; Fax: +86-10-82802871; E-mail: liuzfedu.cn. More

Citation:
Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, Wang F, Liu Z. Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer. Theranostics 2015; 5(6):597-608. doi:10.7150/thno.11546. https://www.thno.org/v05p0597.htm
Other styles

File import instruction

Abstract

Significant evidence has indicated that tumor-associated macrophages (TAMs) play a critical role in the proliferation, invasion, angiogenesis, and metastasis of a variety of human carcinomas. In this study, we investigated whether near-infrared fluorescence (NIRF) imaging using a macrophage mannose receptor (MMR; CD206)-targeting agent could be used to noninvasively visualize and quantify changes in TAMs in vivo. The CD206-targeting NIRF agent, Dye-anti-CD206, was prepared and characterized in vitro and in vivo. By using NIRF imaging, we were able to noninvasively image tumor-infiltrating macrophages in the 4T1 mouse breast cancer model. Importantly, longitudinal NIRF imaging revealed the depletion of macrophages in response to zoledronic acid (ZA) treatment. However, ZA alone did not lead to the inhibition of 4T1 tumor growth. We therefore combined anti-macrophage ZA therapy and tumor cytotoxic docetaxel (DTX) therapy in the mouse model. The results demonstrated that this combination strategy could significantly inhibit tumor growth as well as tumor metastasis to the lungs. Based on these findings, we concluded that CD206-targeted molecular imaging can sensitively detect the dynamic changes in tumor-infiltrating macrophages, and that the combination of macrophage depletion and cytotoxic therapy is a promising strategy for the effective treatment of solid tumors.

Keywords: Optical imaging, CD206, Tumor-associated macrophage, Macrophage depletion, Image-guided therapy.

Citation styles

APA
Sun, X., Gao, D., Gao, L., Zhang, C., Yu, X., Jia, B., Wang, F., Liu, Z. (2015). Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer. Theranostics, 5(6), 597-608. https://doi.org/10.7150/thno.11546.

ACS
Sun, X.; Gao, D.; Gao, L.; Zhang, C.; Yu, X.; Jia, B.; Wang, F.; Liu, Z. Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer. Theranostics 2015, 5 (6), 597-608. DOI: 10.7150/thno.11546.

NLM
Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, Wang F, Liu Z. Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer. Theranostics 2015; 5(6):597-608. doi:10.7150/thno.11546. https://www.thno.org/v05p0597.htm

CSE
Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, Wang F, Liu Z. 2015. Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer. Theranostics. 5(6):597-608.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use